UK-based Alliance Pharma is weighing up both transformational and bolt-on acquisitions to expand its consumer healthcare portfolio, according to chief executive officer Peter Butterfield.
Speaking as the company reported its first half results, Butterfield said Alliance was looking for deals which would further enhance...







